FBRX - Forte Biosciences, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
14.19 -1.27 (-8.95%)	---	---	---	---	-1.27 (-8.95%)	0.0 (0.0%)	0.0 (0.0%)

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.96
Diluted EPS:: -0.96
Basic P/E:: -13.4583
Diluted P/E:: -13.4583
RSI(14) 1m:: 70.69
VWAP:: 12.9
RVol:: 1.2718

Events

Period	Kind	Movement	Occurred At
10m	Price increase 10m	14.65 +0.45 (+3.17%)	Oct 15 09:42
1m	Price increase 1m	14.65 +0.65 (+4.64%)	Oct 15 09:42
1m	Price decrease 1m	14.0 -0.2 (-1.41%)	Oct 15 09:41